Madeleine Willkom - Concepedia

Author

Madeleine Willkom

Gilead Sciences (United States)

Also Known As

M. Willkom, Madeleine Willkom

Publications

524

Citations

H-Index

Concepts

All Affiliations

Gilead Sciences (United States)

About

Madeleine Willkom is an author at Gilead Sciences (United States) specializing in medicine, drug discovery, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	61
2	Natural Sciences	1	1	11
3	Biochemistry	1	1	11
4	Biomolecular Engineering	1	1	18
5	Hepatology	1	1	32

Madeleine Willkom

Publications

517

Citations

H-Index

Page 1

	Year	Citations
The Th2 Lymphocyte Products IL-4 and IL-13 Rapidly Induce Airway Hyperresponsiveness Through Direct Effects on Resident Airway Cells Rajeev Venkayya, Maggie Lam, Madeleine Willkom, American Journal of Respiratory Cell and Molecular Biology	2002	223
Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors Gabriel Birkuš, Rujuta A. Bam, Madeleine Willkom, Antimicrobial Agents and Chemotherapy	2015	69
Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I Kristen Andreatta, Madeleine Willkom, Ross Martin, Journal of Antimicrobial Chemotherapy	2019	61
Resistance Analysis of Bictegravir-Emtricitabine-Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients through 48 Weeks Rima Acosta, Madeleine Willkom, Ross Martin, Antimicrobial Agents and Chemotherapy	2019	58
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance Rima Acosta, Madeleine Willkom, Kristen Andreatta, JAIDS Journal of Acquired Immune Deficiency Syndromes	2020	34
Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model Serena Gilmore, Danny Tam, Ryan A. Dick, Journal of Hepatology HepatologyViral HepatitisLiver PhysiologyAntiviral ActivityImmunology	2017	32
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus Sarah A. Gilmore, Danny Tam, Tara L. Cheung, PLoS ONE ImmunologyChronic Hepatitis BAntiviral DrugHepatitis B VirusViral Hepatitis	2022	18
Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs Ona Barauskas, Weimei Xing, Esmeralda Aguayo, PLoS ONE Viral Rna ReplicationViral ReplicationPolymerase ActivityBiochemistryHeterotrimer Protein	2017	11
Anti-HBV activity of retinoid drugs in vitro versus in vivo Gabriel Birkuš, Chelsea Snyder, Robert Jordan, Antiviral Research	2019	11

Page 1